Compugen Ltd (CGEN)
2.11
-0.03
(-1.40%)
USD |
NASDAQ |
May 17, 16:00
2.11
0.00 (0.00%)
Pre-Market: 20:00
Compugen Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2022 | 0.353M |
| June 30, 2021 | 0.909M |
| June 30, 2020 | 103.54M |
| June 30, 2019 | 7.519M |
| June 30, 2018 | 20.60M |
| June 30, 2017 | 0.00 |
| June 30, 2016 | 1.19M |
| June 30, 2015 | 0.551M |
| Date | Value |
|---|---|
| June 30, 2014 | 71.84M |
| June 30, 2013 | 13.49M |
| June 30, 2012 | 5.432M |
| June 30, 2011 | 5.886M |
| September 30, 2010 | 9.218M |
| June 30, 2010 | 9.133M |
| September 30, 2009 | 0.108M |
| June 30, 2009 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
0.353M
Minimum
Jun 2022
103.54M
Maximum
Jun 2020
28.08M
Average
4.214M
Median
Cash from Financing (Quarterly) Benchmarks
| Pluri Inc | 0.00 |
| BioLine Rx Ltd | 11.74M |
| XTL Biopharmaceuticals Ltd | -- |
| Can Fite Biofarma Ltd | -- |
| BiomX Inc | -1.324M |
Cash from Financing (Quarterly) Related Metrics
| Free Cash Flow Yield | -34.02% |